E-Therapeutics Plc Stock
Your prediction
E-Therapeutics Plc Stock
Heavy losses for E-Therapeutics Plc today as the stock fell by -€0.008 (-7.610%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for E-Therapeutics Plc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of E-Therapeutics Plc in the next few years
Pros
?
B****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of E-Therapeutics Plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
E-Therapeutics Plc | -7.610% | - | - | - | - | - | - |
Proteome Sciences | - | 0.000% | 0.000% | 11.111% | 6.667% | -57.895% | 185.714% |
Oxford BioMedica PLC | 2.660% | 4.891% | 73.874% | -13.839% | 58.197% | -67.009% | -50.000% |
Evgen Pharma plc | - | 0.000% | 0.000% | -98.438% | -80.000% | -99.383% | - |
News
e-therapeutics plc shares now trading on JP Jenkins
e-therapeutics plc shares now trading on JP Jenkins
Edison issues update on e-therapeutics (ETX): More to come in RNAi therapy discovery
Edison issues update on e-therapeutics (ETX): More to come in RNAi therapy discovery